Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Gepubliceerd in:
1 Nederlandse hepatologie in historisch en toekomstig perspectief hoofdstuk lezen eerste hoofdstuk lezen

2009 | OriginalPaper | Hoofdstuk

7 Leverfalen

Auteurs : Prof.dr. H.J. Metselaar, Dr. B. van Hoek

Gepubliceerd in: Leverziekten

Uitgeverij: Bohn Stafleu van Loghum

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Samenvatting

De lever vervult tal van essentiële functies in het menselijk lichaam, waaronder ontgifting van het bloed en aanmaak van diverse eiwitten en hormonen. Tevens speelt de lever een rol in het afweersysteem. Leverfalen kan omschreven worden als een situatie van onvoldoende werking van de lever bij deze processen. Dit beeld ontstaat wanneer door het verlies van functionele cellen het totale effectieve levervolume beneden een kritische grens komt. In dit hoofdstuk wordt ingegaan op diverse vormen van leverfalen en twee specifieke bij leverfalen voorkomende problemen, namelijk hepatische encefalopathie en verhoogde bloedingsneiging.
vorige hoofdstuk 6 Portale hypertensie
volgende hoofdstuk 8 Leverziekten, ondervoeding en voeding
Literatuur
1.
2.
3.
O’Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273–275.PubMedCrossRef
4.
O’Grady JG. Paracetamol-induced acute liver failure: prevention and management. J Hepatol 1997;26(Suppl 1):41–46.PubMedCrossRef
5.
6.
Korman JD, Volenberg I, Balko J, Webster J, Schiodt FV, Squires RH Jr, Fontana RJ, Lee WM, Schilsky ML. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology 2008;48:1167–1174.PubMedCrossRef
7.
Brouwer RE, Manten A, Leeuwen AM van, Veenendaal RA, Ringers J, Hoek B van. [Een adolescent met hemolytische anemie en stollingsstoornissen als uiting van de ziekte van Wilson, behandeld met levertransplantatie.] Ned Tijdschr Geneeskd 2001;145:316–322.PubMed
8.
9.
Lisman T, Leebeek FW. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg 2007;24:250–258.PubMedCrossRef
10.
Caldwell SH, Hoffman M, Lisman T, Macik BG, Northup PG, Reddy KR, Tripodi A, Sanyal AJ. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology 2006;44:1039–1046.PubMedCrossRef
11.
Bernal W, Auzinger G, Sizer E, Wendon J. Intensive care management of acute liver failure. Semin Liver Dis 2008;28:188–200.PubMedCrossRef
12.
Wendon J, Lee W. Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. Neurocrit Care 2008;9:97–102.PubMedCrossRef
13.
Larsen FS, Wendon J. Prevention and management of brain edema in patients with acute liver failure. Liver Transpl 2008;14:S 90–96.CrossRef
14.
Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 2004;127:1338–1346.PubMedCrossRef
15.
Raschke RA, Curry SC, Rempe S, Gerkin R, Little E, Manch R, Wong M, Ramos A, Leibowitz AI. Results of a protocol for the management of patients with fulminant liver failure. Crit Care Med 2008;36:2244–2248.PubMedCrossRef
16.
Rabadan AT, Spaho N, Hernandez D, Gadano A, de Santibanes SE. Intraparenchymal intracranial pressure monitoring in patients with acute liver failure. Arq Neuropsiquiatr 2008;66:374–377.PubMedCrossRef
17.
Aggarwal S, Brooks DM, Kang Y, Linden PK, Patzer JF. Noninvasive monitoring of cerebral perfusion pressure in patients with acute liver failure using transcranial doppler ultrasonography. Liver Transpl 2008;14:1048–1057.PubMedCrossRef
18.
Macquillan GC, Seyam MS, Nightingale P, Neuberger JM, Murphy N. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl 2005;11:1073–1079.PubMedCrossRef
19.
Schmidt LE, Larsen FS. Prognostic implications of hyperlactatemia, multiple organ failure, and systemic inflammatory response syndrome in patients with acetaminophen-induced acute liver failure. Crit Care Med 2006;34:337–343.PubMedCrossRef
20.
Cholongitas E, O’Beirne J, Betrossian A, Senzolo M, Shaw S, Patch D, Burroughs AK. Prognostic impact of lactate in acute liver failure. Liver Transpl 2008;14:121–122.PubMedCrossRef
21.
Kotoh K, Enjoji M, Kato M, Kohjima M, Nakamuta M, Takayanagi R. A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: A retrospective study. Comp Hepatol 2008;7:6.PubMedCentralPubMedCrossRef
22.
Jalan R. Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure. Neurochem Int 2005;47:78–83.PubMedCrossRef
23.
Fontana RJ. Acute liver failure including acetaminophen overdose. Med Clin North Am 2008;92:761–794, viii.
24.
25.
Kortsalioudaki C, Taylor RM, Cheeseman P, Bansal S, Mieli-Vergani G, Dhawan A. Safety and efficacy of N-acetylcysteine in children with non-acetaminopheninduced acute liver failure. Liver Transpl 2008;14:25–30.PubMedCrossRef
26.
Leonis MA, Balistreri WF. Is there a ‘NAC’ to treating acute liver failure in children? Liver Transpl 2008;14:7–8.PubMedCrossRef
27.
San-Miguel B, Alvarez M, Culebras JM, Gonzalez-Gallego J, Tunon MJ. N-acetyl-cysteine protects liver from apoptotic death in an animal model of fulminant hepatic failure. Apoptosis 2006;11:1945–1957.PubMedCrossRef
28.
Sklar GE, Subramaniam M. Acetylcysteine treatment for non-acetaminophen-induced acute liver failure. Ann Pharmacother 2004;38:498–500.PubMedCrossRef
29.
Raghavan M, Marik PE. Therapy of intracranial hypertension in patients with fulminant hepatic failure. Neurocrit Care 2006;4:179–189.PubMedCrossRef
30.
31.
32.
Blonski W, Siropaides T, Reddy KR. Coagulopathy in liver disease. Curr Treat Options Gastroenterol 2007; 10:464–473.PubMedCrossRef
33.
Li M, Zhang LF, Yang L. Fluids administration and coagulation characteristics in patients with different model for end-stage liver disease scores undergoing orthotopic liver transplantation. Chin Med J (Engl) 2007;120:1963–1968.
34.
Miyake Y, Iwasaki Y, Takaki A, Fujioka S, Takaguchi K, Ikeda H, Kobashi H, Sakaguchi K, Shiratori Y. Lamivudine treatment improves the prognosis of fulminant hepatitis B. Intern Med 2008;47:1293–1299.PubMedCrossRef
35.
Kumar M, Satapathy S, Monga R, Das K, Hissar S, Pande C, Sharma BC, Sarin SK. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 2007;45:97–101.PubMedCrossRef
36.
Tillmann HL, Hadem J, Leifeld L, Zachou K, Canbay A, Eisenbach C, Graziadei I, Encke J, Schmidt H, Vogel W, Schneider A, Spengler U, Gerken G, Dalekos GN, Wedemeyer H, Manns MP. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat 2006;13:256–263.PubMedCrossRef
37.
Kramer DJ, Canabal JM, Arasi LC. Application of intensive care medicine principles in the management of the acute liver failure patient. Liver Transpl 2008;14: S85–S89.PubMedCrossRef
38.
Canabal JM, Kramer DJ. Management of sepsis in patients with liver failure. Curr Opin Crit Care 2008; 14:189–197.PubMedCrossRef
39.
Wu VC, Ko WJ, Chang HW, Chen YS, Chen YW, Chen YM, Hu FC, Lin YH, Tsai PR, Wu KD. Early renal replacement therapy in patients with postoperative acute liver failure associated with acute renal failure: effect on postoperative outcomes. J Am Coll Surg 2007; 205:266–276.PubMedCrossRef
40.
41.
Pugliese F, Ruberto F, Perrella SM, Cappannoli A, Bruno K, Martelli S, Celli P, Summonti D, D’Alio A, Tosi A, Novelli G, Morabito V, Poli L, Rossi M, Berloco PB, Pietropaoli P. Modifications of intracranial pressure after molecular adsorbent recirculating system treatment in patients with acute liver failure: case reports. Transplant Proc 2007;39:2042–2044.PubMedCrossRef
42.
Markiewicz-Kijewska M, Szymczak M, Ismail H, Prokurat S, Teisseyre J, Socha P, Jankowska I, Chyzynska A, Kalicinski P, Migdal M. Liver transplantation for fulminant Wilson’s disease in children. Ann Transplant 2008;13:28–31.PubMed
43.
Faenza S, Baraldi O, Bernardi M, Bolondi L, Coli L, Cucchetti A, Donati G, Gozzetti F, Lauro A, Mancini E, Pinna AD, Piscaglia F, Rasciti L, Ravaioli M, Ruggeri G, Santoro A, Stefoni S. Mars and Prometheus: our clinical experience in acute chronic liver failure. Transplant Proc 2008;40:1169–1171.PubMedCrossRef
44.
Koivusalo AM, Teikari T, Hockerstedt K, Isoniemi H. Albumin dialysis has a favorable effect on amino acid profile in hepatic encephalopathy. Metab Brain Dis 2008;23(4):387–398.PubMedCrossRef
45.
Klammt S, Mitzner SR, Stange J, Loock J, Heemann U, Emmrich J, Reisinger EC, Schmidt R. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Liver Transpl 2008;14:1333–1339.PubMedCrossRef
46.
Ronco C, Tetta C. Extracorporal blood purification: more than diffusion and convection. Does this help? Curr Opin Crit Care 2007;13:662–667.PubMedCrossRef
47.
Karvellas C, Wendon J. MARS in acute-on-chronic liver failure. Indian J Gastroenterol 2007;26:109.PubMed
48.
O’Grady JG. Postoperative issues and outcome for acute liver failure. Liver Transpl 2008;14:S97–S101.PubMedCrossRef
49.
Quaglia A, Portmann BC, Knisely AS, Srinivasan P, Muiesan P, Wendon J, Heneghan MA, O’Grady JG, Samyn M, Hadzic D, Dhawan A, Mieli-Vergani G, Heaton N, Rela M. Auxiliary transplantation for acute liver failure: Histopathological study of native liver regeneration. Liver Transpl 2008;14:1437–1448.PubMedCrossRef
Metagegevens
Titel
7 Leverfalen
Auteurs
Prof.dr. H.J. Metselaar
Dr. B. van Hoek
Copyright
2009
Uitgeverij
Bohn Stafleu van Loghum
Boek
Leverziekten

Print ISBN: 978-90-313-7436-6

Elektronisch ISBN: 978-90-313-7437-3

Copyright: 2009

DOI
https://doi.org/10.1007/978-90-313-7437-3_7